Gene Techno Science Co.,Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2020. For the year ending March 31, 2020, the company expects net sales of JPY 1,050 million, Operating loss of JPY 1,220 million, Ordinary loss of JPY 1,260 million, net loss of JPY 7,260 million or JPY 262.61 per share.